These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33420233)

  • 1. Validation and comparison of non-invasive prediction models based on liver stiffness measurement to identify patients who could avoid gastroscopy.
    Hu Y; Wen Z
    Sci Rep; 2021 Jan; 11(1):150. PubMed ID: 33420233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment.
    Berger A; Ravaioli F; Farcau O; Festi D; Stefanescu H; Buisson F; Nahon P; Bureau C; Ganne-Carriè N; Berzigotti A; de Ledinghen V; Petta S; Calès P;
    Clin Gastroenterol Hepatol; 2021 Apr; 19(4):777-787.e17. PubMed ID: 32562889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease.
    Galizzi HO; Couto CA; Taranto DOL; Araújo SIO; Vilela EG
    Ann Hepatol; 2021; 20():100229. PubMed ID: 32745630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
    Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
    J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
    Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
    J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of noninvasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease.
    Llop E; Lopez M; de la Revilla J; Fernandez N; Trapero M; Hernandez M; Fernández-Carrillo C; Pons F; Martinez JL; Calleja JL
    J Gastroenterol Hepatol; 2017 Nov; 32(11):1867-1872. PubMed ID: 28295587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease.
    Lee HA; Kim SU; Seo YS; Lee YS; Kang SH; Jung YK; Kim MY; Kim JH; Kim SG; Suk KT; Jung SW; Jang JY; An H; Yim HJ; Um SH
    Liver Int; 2019 Jun; 39(6):1071-1079. PubMed ID: 30589490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
    Zhou H; Long J; Hu H; Tian CY; Lin SD
    World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease.
    Vanderschueren E; Armandi A; Kwanten W; Cassiman D; Francque S; Schattenberg JM; Laleman W
    Am J Gastroenterol; 2024 Mar; ():. PubMed ID: 38502095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease.
    Tosetti G; Primignani M; La Mura V; D'Ambrosio R; Degasperi E; Mezzina N; Viganò M; Rumi M; Fracanzani AL; Lombardi R; Fargion S; Fraquelli M; Aghemo A; Lampertico P
    Dig Liver Dis; 2019 Aug; 51(8):1135-1140. PubMed ID: 30691777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VariScreen secures the screening of high-risk varices in patients with hepatitis B virus-related cirrhosis beyond Baveno VI criteria.
    Tan M; Zhang W; Zhou H; Liu Y; Lu T; Zhang Y; Li C; Yang Y; Wu Y; Hu H; Li Y; Yang F; Lin S
    Front Physiol; 2022; 13():1006657. PubMed ID: 36237519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baveno Criteria Safely Identify Patients With Compensated Advanced Chronic Liver Disease Who Can Avoid Variceal Screening Endoscopy: A Diagnostic Test Accuracy Meta-Analysis.
    Szakács Z; Erőss B; Soós A; Mátrai P; Szabó I; Pétervári E; Bajor J; Farkas N; Hegyi P; Illés A; Solymár M; Balaskó M; Sarlós P; Szűcs Á; Czimmer J; Vincze Á; Pár G
    Front Physiol; 2019; 10():1028. PubMed ID: 31481896
    [No Abstract]   [Full Text] [Related]  

  • 13. Are we missing varices by implementing Baveno-VI recommendation of not screening patients with Compensated Advanced Chronic Liver Disease?
    Ali FS; Bader N; Zuberi BF; Rasheed T
    Pak J Med Sci; 2022; 38(1):1-8. PubMed ID: 35035392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of biochemical parameters for non-invasive screening of oesophageal varices in comparison to elastography-based approach in patients with compensated advanced chronic liver disease.
    Pastrovic F; Madir A; Podrug K; Lucijanic M; Bokun T; Zelenika M; Mustapic S; Unic A; Derek L; Grgurevic I
    Biochem Med (Zagreb); 2022 Jun; 32(2):020712. PubMed ID: 35799983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease.
    Augustin S; Pons M; Maurice JB; Bureau C; Stefanescu H; Ney M; Blasco H; Procopet B; Tsochatzis E; Westbrook RH; Bosch J; Berzigotti A; Abraldes JG; Genescà J
    Hepatology; 2017 Dec; 66(6):1980-1988. PubMed ID: 28696510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of screening strategies with two new tests to score and diagnose varices needing treatment.
    Calès P; Ravaioli F; Berger A; Farcau O; Festi D; Stefanescu H; Vitellius C; Nahon P; Bureau C; Ganne-Carriè N; Berzigotti A; de Ledinghen V; Petta S
    Clin Res Hepatol Gastroenterol; 2022; 46(7):101925. PubMed ID: 35470108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
    Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
    Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Moctezuma-Velazquez C; Saffioti F; Tasayco-Huaman S; Casu S; Mason A; Roccarina D; Vargas V; Nilsson JE; Tsochatzis E; Augustin S; Montano-Loza AJ; Berzigotti A; Thorburn D; Genesca J; Abraldes JG
    Am J Gastroenterol; 2019 Mar; 114(3):446-452. PubMed ID: 30315285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a nomogram for predicting varices needing treatment in compensated advanced chronic liver disease: A multicenter study.
    Wang J; Wei W; Duan Z; Li J; Liu Y; Liu C; Zhang L; Zhang Q; Zhou S; Zhang K; Gao F; Wang X; Liao Y; Xu D; Huang Y; Wang S; Hu W; Mao H; Xu M; Dang T; Wu B; Yang L; Liu D; Qi X
    Saudi J Gastroenterol; 2021; 27(6):376-382. PubMed ID: 34341248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Noninvasive Tools to Decide the Need for Beta-Blockers for Variceal Bleeding Prophylaxis in Compensated Advanced Liver Disease: A Decision Curve Analysis.
    Agarwal S; Sharma S; Jindal A; Singh S; Jagdish R; Gunjan D; Sarin SK; Saraya A
    J Clin Exp Hepatol; 2022; 12(3):917-926. PubMed ID: 35677505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.